₹5.40
(Market cap
₹77 Cr
Recently Viewed
Clear AllMarket cap
₹77 Cr
Revenue (TTM)
₹318 Cr
P/E Ratio
19
P/B Ratio
2.1
Div. Yield
0.4 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹4 Cr
ROE
11.5 %
ROCE
13 %
Industry P/E
30.64
EV/EBITDA
9.8
Debt to Equity
0.6
Book Value
₹54.8
EPS
₹6
Face value
10
Shares outstanding
6,807,800
CFO
₹33.45 Cr
EBITDA
₹47.25 Cr
Net Profit
₹17.87 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aristo Bio-Tech
| -5.4 | 30.5 | 9.3 | -14.0 | 24.0 | -- | -- |
|
BSE Commodities
| 5.1 | 15.1 | 5.2 | 14.0 | 18.0 | 13.5 | 16.0 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Aristo Bio-Tech
| -9.8 | 104.0 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Commodities
| 12.5 | 8.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aristo Bio-Tech
|
113.6 | 77.3 | 318.1 | 4.1 | -- | 11.5 | 19 | 2.1 |
| 4,670.5 | 21,028.0 | 5,620.6 | 670.4 | 13.4 | 22.4 | 31.4 | 6.5 | |
| 259.3 | 3,356.5 | 500.5 | 13.2 | 5.5 | 1.9 | 254 | 4.8 | |
| 1,393.6 | 2,320.2 | 1,240.4 | 132.3 | 13.1 | 12.2 | 17.5 | 1.9 | |
| 1,062.2 | 4,786.9 | 1,978.5 | 265.0 | 16.3 | 18 | 18.1 | 3.0 | |
| 699.7 | 2,030.7 | 2,072.7 | 140.8 | 9.5 | 12.4 | 14.3 | 1.7 | |
| 154.2 | 3,602.8 | 1,424.9 | -44.7 | -1.1 | -13.7 | -- | 5.3 | |
| 256.5 | 4,987.2 | 2,871.0 | 167.0 | 7.8 | 11.7 | 29.9 | 2.4 | |
| 1,109.7 | 10,014.5 | 5,031.2 | 565.9 | 9.9 | 21.9 | 17.7 | 3.6 | |
| 434.7 | 21,732.8 | 3,234.0 | 531.4 | 18.3 | 17.8 | 40.9 | 6.6 |
No Review & Analysis are available.
Manufacture of insecticides, rodenticides, fungicides, herbicides
Incorporated
2005
Chairman
Narendra Singh Barhat
Managing Director
Narendra Singh Barhat
Headquarters
Vadodara Dist, Gujarat
Website
Looking for more details about Aristo Bio-Tech And Lifescience Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Aristo Bio-Tech And Lifescience Ltd is ₹113.55 (NSE) as of 24-Apr-2026 IST. Aristo Bio-Tech And Lifescience Ltd has given a return of 24% in the last 3 years.
The P/E ratio of Aristo Bio-Tech And Lifescience Ltd is 19.03 times as on 24-Apr-2026, a 38 discount to its peers’ median range of 30.64 times.
The P/B ratio of Aristo Bio-Tech And Lifescience Ltd is 2.07 times as on 24-Apr-2026, a 33 discount to its peers’ median range of 3.07 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
19.47
|
2.12
|
|
2024
|
10.91
|
1.27
|
|
2023
|
10.71
|
1.27
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Aristo Bio-Tech And Lifescience Ltd are Rs 145.30 and Rs 74.30 as of 24-Apr-2026.
Aristo Bio-Tech And Lifescience Ltd has a market capitalisation of ₹ 77 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Aristo Bio-Tech And Lifescience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.